Damian Bialonczyk

Metabolism & Global Medical Lead

Roche

Andrew Young

Chief Scientific & Medical Officer

I2O Therapeutics

Jay Caplan

Founder & President

Fractyl Health

Belle van Rosmalen

Director - Incretin Outcomes

Eli Lilly & Co.

Jacek Mokrosinski

Senior Scientist

Novo Nordisk

Hong Chen

Director, Search & Evaluation: USA

Novo Nordisk

Jerry Colca

Chief Scientific Officer

Cirius Therapeutics

Adam Bell

Vice President - Translational Medicine & Regulatory Affairs

Neuraly

Marco Falasca

Professor

Universita Degli Studi Di Parma

Scott Harris

Chief Medical Officer

Altimmune

Zohar Barbash

Chief Technology Officer

Lembas Bio

Elisa Araldi

Professor

University of Parma

David Bearss

President & Chief Executive Officer ,Co-Founder

Biolexis Therapeutics

David Glass

Vice President - Research

Regeneron

Jason Mastaitis

Sr. Principal Scientist

Regeneron

Johan Fredrik Paulsson

Director - Incretin & Amylin Biology

Novo Nordisk

Robert Beardsley

President & CEO

Cirius Therapeutics

Simon Bruce

Vice-President - Drug Development Solutions

ICON

Ansarullah

Associate Director - Metabolic Phenotyping Core, Centre for Biometric Analysis

The Jackson Laboratory

Speaker to be confirmed

Antaros Medical

Speaker to be confirmed

Perspectum

Jennifer Linge

PhD, Lead Scientist - Personalized Medicine

AMRA

Speaker from the

National Academy of Sports Medicine

Mitchell Steiner

Chairman, Chief Executive Officer & President

Veru Inc.

Iris Grossman

Chief Therapeutics Officer

Eleven Therapeutics